Marc A. Wollmer
Wilhelm Klein Str 27
Basel, BS 4012, Switzerland
Basel, BS 4012, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Correction: FaReWell Depression - a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression.
Journal: Frontiers in psychiatry
Published: August 05, 2026
FaReWell Depression - a randomized controlled trial of a physiotherapeutic program for the facial rehabilitation of wellbeing in depression.
Journal: Frontiers in psychiatry
Published: January 28, 2026
Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study.
Journal: Toxins
Published: April 07, 2023
Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.
Journal: Journal of Alzheimer's disease : JAD
Published: December 04, 2022
Is there an association between depression, anxiety disorders and COVID-19 severity and mortality? A multicenter retrospective cohort study conducted in 50 hospitals in Germany.
Journal: Journal of psychiatric research
Published: October 19, 2022
Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder.
Journal: European archives of psychiatry and clinical neuroscience
Published: October 11, 2022
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 01, 2022
Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder.
Journal: Scientific reports
Published: October 11, 2021
Comment on effects of botulinum toxin type A on mood and cognitive function in patients with Parkinson's disease and depression.
Journal: American journal of translational research
Published: June 24, 2021
Reply to: "Letter to the Editor: Claims about the effects of botulinum toxin on depression should raise some eyebrows".
Journal: Journal of psychiatric research
Published: May 01, 2021
Last Updated: 09/26/2026